chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Cyanosis, Feeling cold, Pain in extremity, Peripheral coldness
Clinical narrative: Extremities went cold several times; Hands went purple with cold for about 30 minutes; Pain in arm; Began feeling cold; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 12Apr2021 at 17:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included dysmenorrhea in the past also due to her cold nature and blood deficiency, which had been treated successfully with herbs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient reported that she did not receive any medication but received many supplements and herbs "hot, spicy" within two weeks of the vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. The patient reported that when she had received previous vaccines (unspecified) when she was a child, she had experienced events like high blood pressure, chills, fever and fainting. The patients last vaccine was in the year 1994. The patient reported that upon receiving the COVID-19 vaccine, she did not experience immediate adverse events like those she experienced during the previous vaccines. On 13Apr2021 at 02:00, about 9 hours after the vaccine, the patient began feeling cold and she had pain in her arm. On 13Apr2021 at 18:30, 25 hours after the vaccine, the patient reported that her hands went purple with cold for about 30 minutes and then went back to normal as the patient reported that she exercised and had a diet of hot and spicy herbs which she had been taking for several years because they warmed her (by nature she was a "cold person"). The following day on 14Apr2021, the patient reported that her extremities went cold several times. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the event feeling cold was resolved on an unspecified date in Apr2021. The clinical outcome of the event hands went purple with cold for about 30 minutes was resolved on 13Apr2021 at 19:00. The clinical outcome of the events extremities went cold several times and pain in arm was resolved on 14Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Hypokinesia, Lymph node pain, Lymphadenopathy
Clinical narrative: Lymph node appeared on the right side on the collarbone. Its painful and cant move the arm too much.; Lymph node appeared on the right side on the collarbone. Its painful and cant move the arm too much.; Lymph node appeared on the right side on the collarbone. Its painful and cant move the arm too much.; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 12Apr2021 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included amitriptyline (MANUFACTURER UNKNOWN) for unspecified indication from unknown date and unknown if ongoing . The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 22Mar2021 at 12:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 16:00, the patient experienced lymph node appeared on the right side on the collarbone. It was painful and patient could not move the arm too much. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event lymph node appeared on the right side on the collarbone and it was painful and patient could not move the arm too much was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Fatigue, Feeling cold, Feeling hot
Clinical narrative: Tingling and numbness in arms; Tingling and numbness in arms; Feelings of hot and cold; Feelings of hot and cold; Tiredness; Joint pain; Lightheadedness; Heart racing; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the right arm on 02Apr2021 at 13:45 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, blood progesterone low and sulfonamide allergy. Concomitant medications included progesterone (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), cyanocobalamin (B12), colecalciferol (VITAMIN D) and melatonin (MANUFACTURER UNKNOWN) on unknown date for unspecified indication and unknown if its ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, the patient experienced tingling and numbness in arms, feelings of hot and cold, tiredness, joint pain, light-headedness and heart racing. No therapeutic measures were taken as a result of the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tingling and numbness in arms, feelings of hot and cold, tiredness, joint pain, light-headedness and heart racing was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Palpitations, Paraesthesia
Clinical narrative: Tingling and numbness in arms; Tingling and numbness in arms; Feelings of hot and cold; Feelings of hot and cold; Tiredness; Joint pain; Lightheadedness; Heart racing; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the right arm on 02Apr2021 at 13:45 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, blood progesterone low and sulfonamide allergy. Concomitant medications included progesterone (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), cyanocobalamin (B12), colecalciferol (VITAMIN D) and melatonin (MANUFACTURER UNKNOWN) on unknown date for unspecified indication and unknown if its ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, the patient experienced tingling and numbness in arms, feelings of hot and cold, tiredness, joint pain, light-headedness and heart racing. No therapeutic measures were taken as a result of the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tingling and numbness in arms, feelings of hot and cold, tiredness, joint pain, light-headedness and heart racing was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pyrexia, Vaccination site pain
Clinical narrative: Vaccination site pain; Tired; Mild headache; Chills; Fever; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right on 10Apr2021 at 14:15 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included seizures, white blood cell count low and had sulfa allergy. The patient did not receive any medication within two weeks of vaccination. Concomitant medication included phenobarbital (MANUFACTURER UNKNOWN), phenytoin (DILANTIN) all for unknown indication, from unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 20Mar2021 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19.Since, vaccination the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 09:00 the patient experienced injection site pain, tired, mild headache, fever, chills the day after 2nd dose. The chills were due to fever. The patient took Tylenol 1000mg, every 6 hours, fever was gone and the  patient was drinking plenty of fluids. Therapeutic measures were taken as a result of adverse events and included treatment with Tylenol (1000mg, every 6 hours). The clinical outcome of the events injection site pain, tired, mild headache, chills was recovering at the time of this report. The clinical outcome of the event fever was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Pruritus, Urticaria
Clinical narrative: She developed hives on April 11th and her whole body was itchy. She was unable to sleep on April 11th due to being itchy; She developed hives on April 11th and her whole body was itchy. She was unable to sleep on April 11th due to being itchy; She developed hives on April 11th and her whole body was itchy. She was unable to sleep on April 11th due to being itchy; This is a spontaneous report from a contactable consumer. A adult female patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 09Apr2021 (age at vaccination unknown) as a single dose for COVID-19 immunisation. Medical history and concomitant medications taken within two weeks of vaccination were not reported. It was not reported if the patient received any other vaccines within four weeks prior to the vaccination. The reporters friend, the patient informed the reporter on 12Apr2021, that she received the Pfizer vaccine on Friday, 09Apr2021. The patient developed hives on 11Apr2021 and her whole body was itchy. She was unable to sleep on 11Apr2021 due to being itchy. Therapeutic measures were taken as a result of hives, itchy and being unable to sleep which included treatment with Benadryl. The clinical outcome of the events developed hives on 11Apr2021 and whole body was itchy; was unable to sleep on 11Apr2021 due to being itchy was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Malaise, Pain, Pyrexia
Clinical narrative: Soreness vaccination site; chills; aches; fever; headache; general malaise; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0162) via an unspecified route of administration in the left arm on 14Apr2021 at 07:45 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's hypothyroidism. The patient had no known allergies to medications, food or other products. Concomitant medications included SYNTHROID and vitamin D (MANUFCATURER UNKNOWN). The patient had not received any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 49-years-old) as a single dose for COVID-19 immunisation. On 14Apr2021 at 16:00, the patient experienced soreness injection site, chills, aches, headache and general malaise. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the events soreness injection site, chills, aches, headache and general malaise were recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness vaccination site; chills; aches; fever; headache; general malaise; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0162) via an unspecified route of administration in the left arm on 14Apr2021 at 07:45 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's hypothyroidism. The patient had no known allergies to medications, food or other products. Concomitant medications included SYNTHROID and vitamin D (MANUFCATURER UNKNOWN). The patient had not received any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 49-years-old) as a single dose for COVID-19 immunisation. On 14Apr2021 at 16:00, the patient experienced soreness injection site, chills, aches, headache and general malaise. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the events soreness injection site, chills, aches, headache and general malaise were recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Hives and itchiness on stomach and lower back. Hives on the inside of the thighs, but not itchy.; itchiness on stomach and lower back.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 09Apr2021 at 17:00 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On an unknown date in Apr2021, the patient experienced hives and itchiness on stomach and lower back and hives on the inside of the thighs, but not itchy. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of events which included treatment with Benadryl. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events hives and itchiness on stomach and lower back and hives on the inside of the thighs, but not itchy were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Tooth infection
Clinical narrative: tooth infection; This is a spontaneous report received from a Pfizer sponsored program. A female consumer (patient herself) of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiration date was not reported) via an unspecified route of administration on 07Mar2021 as DOSE 1, SINGLE and patient had received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiration date was not reported) via an unspecified route of administration on 27Mar2021 as DOSE 2, SINGLE both for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced tooth infection on an unspecified date. It was reported that patient was asking if she can take the prescribed antibiotic medication (Clindamycin) for tooth infection. She added that she already completed the 1st and 2nd dose of the COVID-19 vaccine. The outcome of event was unknown.  No follow-up attempts are needed. Information on the lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Chest discomfort, Decreased appetite, Dizziness, Headache
Clinical narrative: Food had different off taste for 8 hours; Loss of appetite; Smell of drilled teeth; Nauseous; Headache; Chest tightness; Sore arm; Light headed; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8729), via an unspecified route of administration in the left arm on 10Apr2021 at 14:45 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma, allergies, arthritis and fruit allergy (stone fruit). Concomitant medications included fluticasone propionate, salmeterol xinafoate (ADVAIR), fluticasone propionate (FLONASE) and estradiol (MANUFACTURER UNKNOWN); all from unknown dates for unspecified indications. The patient previously took paroxetine hydrochloride (PAXIL) and loratadine (CLARITIN); both on unknown dates for unspecified indications and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 16:00, the patient experienced food had different off taste for 8 hours, loss of appetite, smell of drilled teeth for 8 hours, nauseous, headache, chest tightness, sore arm and light headed. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events food had different off taste for 8 hours and smell of drilled teeth for 8 hours were resolved with sequelae on 11Apr2021 at 00:00. The clinical outcome of the events loss of appetite, nauseous, headache, chest tightness, sore arm and light headed were resolved with sequelae on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Parosmia
Clinical narrative: Food had different off taste for 8 hours; Loss of appetite; Smell of drilled teeth; Nauseous; Headache; Chest tightness; Sore arm; Light headed; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8729), via an unspecified route of administration in the left arm on 10Apr2021 at 14:45 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma, allergies, arthritis and fruit allergy (stone fruit). Concomitant medications included fluticasone propionate, salmeterol xinafoate (ADVAIR), fluticasone propionate (FLONASE) and estradiol (MANUFACTURER UNKNOWN); all from unknown dates for unspecified indications. The patient previously took paroxetine hydrochloride (PAXIL) and loratadine (CLARITIN); both on unknown dates for unspecified indications and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 16:00, the patient experienced food had different off taste for 8 hours, loss of appetite, smell of drilled teeth for 8 hours, nauseous, headache, chest tightness, sore arm and light headed. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events food had different off taste for 8 hours and smell of drilled teeth for 8 hours were resolved with sequelae on 11Apr2021 at 00:00. The clinical outcome of the events loss of appetite, nauseous, headache, chest tightness, sore arm and light headed were resolved with sequelae on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of bnt162b2 (Pfizer Covid vaccine, Solution for injection, Batch/lot number: Unknown), via an unspecified route on an unknown date as a single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date, patient experienced sore arm. The clinical outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Severe bloody noses every day since getting the vaccine; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8734) via an unspecified route of administration on 12Apr2021 at 12:45 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Apr2021 the patient experienced severe bloody noses every day since getting the vaccine. No therapeutic measures were taken as a result of the event. The clinical outcome of the event severe bloody noses every day since getting the vaccine was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Delayed allergic reaction (rash) atinjection site. Irregular shape butaround 1.5in in length and 1in inwidth; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 07Apr2021 at 09:45 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history were not reported. The patient did not have allergies to medications, food, or other products. Concomitant medications included  ethinylestradiol, norgestimate(ORTHO TRI-CYCLEN LO) and omega 3, greens supplement . The patient did not receive any other vaccines within four weeks prior to the vaccination .Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 14Apr2021 at 06:00, the patient had delayed allergic reaction (rash) at injection site which was of irregular shape but around 1.5in in length and 1in in width. The patient did not receive any treatment for the event. The clinical outcome of the event delayed allergic reaction (rash) at injection site  was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected. .
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Headache, Rhinorrhoea
Clinical narrative: pressure headache; loss of appetite; slight runny nose; This is a spontaneous report from a contactable consumer, the patient. An elderly non-pregnant female patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 12Apr2021 at 03:45 (age at vaccination unknown) as a single dose for COVID-19 immunisation. Medical history included obesity. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination included verbascum thapsus leaf (MULLEIN) (reported as Mullein Leaf), acetylsalicylic acid (ASPIRIN), advanced D+K and Red Yi, all from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021, the patient experienced pressure headache, loss of appetite, slight runny nose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events pressure headache, loss of appetite, slight runny nose was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Nasopharyngitis, Tremor
Clinical narrative: hands were shaking; cold; headache in my right temple and right base of head which lasted most of thetime all of this was going o; then started heating up. Ears first then whole body. My temperature was over 100 degrees, no sweating but felt like I was burning up.; This is a spontaneous report from a contactable consumer, the patient. A 66-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW-0150) via an unspecified route of administration in the left arm on 03Apr2021 at 11:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included Hashimoto's disease and Raynaud's. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), vitamin B (MANUFACTURER UNKNOWN), cholecalciferol (vitamin D3) (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN) and curcuma longa (turmeric curcu) (MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN-6208) via an unspecified route of administration in the left arm on 15Mar2021 at 11:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. On 03Apr2021 at 21:30, the patient experienced whole body was cold and hands were shaking. The patient never felt this type of freezing cold ever. Also, had a headache in right temple and right base of head which lasted most of the time, all of this was going on. The patient then started heating up. Ears first then whole body. The temperature was over 100 degrees, no sweating but felt like she was burning up. It would let up a little for about a half-hour at a time but start again. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, cold and hands were shaking, headache in right temple and right base of head and temperature was over 100 degrees was resolved in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain
Clinical narrative: Left arm pit and areas south of the arm pit painful.; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Apr2021 at 10:15 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. The patient received unspecified prescribed medications within two weeks of vaccination. Medical history was not reported. The patient was allergic to codeine and penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient had received other prescribed medications within 2 weeks of vaccination. On 13Apr2021 at 14:30, the patient felt her left arm pit and areas south of the arm pit were painful. No therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event painful armpit was recovering at the time of the reporting.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Peripheral swelling
Clinical narrative: Leg swelling; Dizzy; Headache; This is a spontaneous report from a contactable consumer, the patient. A 79-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date, the patient experienced leg swelling, headache and was dizzy after two weeks prolong. The clinical outcome of the events leg swelling, headache and dizzy were unknown.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash all over my upper body; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 12:00 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies to medication, food or any other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included loratadine (MUNUFACTURER UNKNOWN) for unknown indication from unknown start date. On 12Apr2021, the patient experienced rash all over her upper body. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash all over upper body was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Severe headache; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old, male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0153) via an unspecified route on 14Apr2021 at 10:00 in the left arm (at an age of 30-year-old) as single dose for COVID-19 immunisation. Medical history was not reported. The patient received daily vitamins (MANUFACTURER UNKNOWN) within 2 weeks of COVID-19 vaccine for an unknown indication. Previously, the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route on 24Mar2021 at 10:00 in the left arm as single dose for COVID-19 immunisation. On 14Apr2021 at 18:00, the patient experienced severe headache. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event of severe headache was recovered on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Blood test, Drug level decreased
Clinical narrative: Tacrolimus levels dropped a lot; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), on an unspecified date at dose 2, single for COVID-19 immunisation; patient started to receive tacrolimus as anti-rejection medicines. Medical history included kidney transplant 5 years prior the report, in 2016, and all was good. Concomitant medications were not reported. The patient received the first dose of BNT162B2 for COVID-19 immunisation on an unspecified date. The patient received the 2 doses of vaccine with any issues. The first bloodwork since the vaccine were fine except for tacrolimus levels that dropped a lot. That was one of the patient anti-rejection medicines. That was a big concern to the patient. The action taken with tacrolimus was unknown. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia
Clinical narrative: Fever of 104 starting the next morning.; Chills; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: #er8737) via an unspecified route of administration in the left arm on 12Apr2021 at 13:45 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history and no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6207) via an unspecified route of administration in the left arm on 22Mar2021 at 13:45 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced fever of 104 (unspecified units) starting the next morning, chills on 13Apr2021 at 06:00. Therapeutic measures were taken as a result of fever of 104 (unspecified units) starting the next morning, chills and included treatment with Advil. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events fever of 104 (unspecified units) starting the next morning, chills was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash morbilliform
Clinical narrative: an itchy red on my face, then chest, then back, and over a few hours, they would pop up all over, not in clusters.; red on face; Bump is measlelike, not a rash; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0158) via an unspecified route of administration in the left arm on 14Apr2021 at 17:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included diclofenac potassium (ZIPSOR), gabapentin (MANUFACTURER UNKNOWN), steroid shot injection and D sup; all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730) via an unspecified route of administration in the left arm on 24Mar2021 at 11:45 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 17:15, within minutes, the patient noticed an itchy red on face, then chest, back and over a few hours, they would pop up all over, not in clusters. Bump was measles like but not a rash. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with Benadryl by mouth. The clinical outcome of the events an itchy red on my face, then chest, then back, and over a few hours, they would pop up all over, not in clusters, red on face and bump measle like, not a rash were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: developed vertigo type symptoms; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the arm left on 09Apr2021 at 08:15 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, hemolytic anemia (currently not active) and penicillin allergy. Concomitant medications included montelukast (MANUFACTURER UNKNOWN) and loratadine (MANUFACTURER UNKNOWN); from an unknown date for unspecified indication. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 19Mar2021 at 08:30(at the age of 36-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 06:00, second day after the vaccination, the patient developed vertigo type symptoms. she was currently on day 5 of these symptoms, though it seems to be getting better each day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event vertigo type symptoms was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: Sore throat; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in left arm on 10Apr2021 at 08:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included high blood pressure. The patient had no known allergies. The concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in right arm on 20Mar2021 at 08:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 10Apr2021 at 14:00, the patient had experienced sore throat. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported event. The clinical outcome of the event sore throat was not recovered at the time of report.   No follow-up attempts are needed. Information about lot\batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Lymphadenopathy, Myalgia, Nausea, Pyrexia
Clinical narrative: Fever; Nausea; Clementine size lymph node under left armpit; Sore forearm muscle; Left elbow joint pain; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Mar2021(at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN) from unknown date and for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Mar2021 at 21:00, the patient experienced fever, nausea with throwing up, clementine size lymph node under left armpit, sore forearm muscle ongoing for more than a month. Left elbow joint pain, recently pulsated throughout the night for 12 hours. Lymph node swelling went away within 48 hours, but left arm muscle weakness/soreness and left elbow joint pain continues into a month after shot. The patient had underwent Nasal Swab test on an unknown date and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of these adverse events. The clinical outcome of the events fever, nausea were recovered with sequelae on an unknown date in Mar2021 while that of the events clementine size lymph node under left armpit was recovered with sequelae on 18Mar2021, after the duration of 2 days, and the events muscle weakness/soreness and left elbow joint pain was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Fever; Nausea; Clementine size lymph node under left armpit; Sore forearm muscle; Left elbow joint pain; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Mar2021(at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN) from unknown date and for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Mar2021 at 21:00, the patient experienced fever, nausea with throwing up, clementine size lymph node under left armpit, sore forearm muscle ongoing for more than a month. Left elbow joint pain, recently pulsated throughout the night for 12 hours. Lymph node swelling went away within 48 hours, but left arm muscle weakness/soreness and left elbow joint pain continues into a month after shot. The patient had underwent Nasal Swab test on an unknown date and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of these adverse events. The clinical outcome of the events fever, nausea were recovered with sequelae on an unknown date in Mar2021 while that of the events clementine size lymph node under left armpit was recovered with sequelae on 18Mar2021, after the duration of 2 days, and the events muscle weakness/soreness and left elbow joint pain was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; Low grade fever; Sweats; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 11:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, hashimoto's disease, and penicillin allergy. Concomitant medications included levothyroxine sodium (SYNTHROID), liothyronine (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 17:00, the patient experienced sore arm, low grade fever, sweats. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events sore arm, low grade fever, sweats was recovering.   No follow-up attempts are needed; information about lot/batch number cannot be obtained